ICAgen and Bristol-Myers Squibb renew collaboration

ICAgen ( Research Triangle Park, N.C.) renewed its 1997 agreement with BMY to discover and develop small molecule compounds targeting ion channels involved in atrial fibrillation, or irregular heart b...